149 related articles for article (PubMed ID: 870569)
1. Severe generalized glutathione reductase deficiency after antitumor chemotherapy with BCNU" [1,3-bis(chloroethyl)-1-nitrosourea].
Frischer H; Ahmad T
J Lab Clin Med; 1977 May; 89(5):1080-91. PubMed ID: 870569
[TBL] [Abstract][Full Text] [Related]
2. Consequences of erythrocytic glutathione reductase deficiency.
Frischer H; Ahmad T
J Lab Clin Med; 1987 May; 109(5):583-8. PubMed ID: 3572207
[TBL] [Abstract][Full Text] [Related]
3. Glutathione reductase deficiency and platelet dysfunction induced by 1,3-bis(2-chloroethyl)-1-nitrosourea.
McKenna R; Ahmad T; Ts'ao CH; Frischer H
J Lab Clin Med; 1983 Jul; 102(1):102-15. PubMed ID: 6687896
[TBL] [Abstract][Full Text] [Related]
4. Erythrocytic glutathione reductase deficiency in a hospital population in the United States.
Frischer H
Am J Hematol; 1977; 2(4):327-34. PubMed ID: 602923
[TBL] [Abstract][Full Text] [Related]
5. Active site-specific inhibition by 1,3-bis(2-chloroethyl)-1-nitrosourea of two genetically homologous flavoenzymes: glutathione reductase and lipoamide dehydrogenase.
Ahmad T; Frischer H
J Lab Clin Med; 1985 Apr; 105(4):464-71. PubMed ID: 3920338
[TBL] [Abstract][Full Text] [Related]
6. Glutathione reductase-deficient erythrocytes as host cells of malarial parasites.
Zhang Y; König I; Schirmer RH
Biochem Pharmacol; 1988 Mar; 37(5):861-5. PubMed ID: 3278713
[TBL] [Abstract][Full Text] [Related]
7. Glutathione, cell proliferation, and 1,3-bis-(2-chloroethyl)-1-nitrosourea in K562 leukemia.
Frischer H; Kennedy EJ; Chigurupati R; Sivarajan M
J Clin Invest; 1993 Dec; 92(6):2761-7. PubMed ID: 8254030
[TBL] [Abstract][Full Text] [Related]
8. Preferential effects of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) on pulmonary glutathione reductase and glutathione/glutathione disulfide ratios: possible implications for lung toxicity.
Smith AC; Boyd MR
J Pharmacol Exp Ther; 1984 Jun; 229(3):658-63. PubMed ID: 6726651
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of inhibition of red blood cell glutathione reductase activity by BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea).
Shinohara K; Tanaka KR
Clin Chim Acta; 1979 Mar; 92(2):147-52. PubMed ID: 39688
[TBL] [Abstract][Full Text] [Related]
10. The effects of BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea) and CCNU (1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea) on glutathione reductase and other enzymes in mouse tissue.
Maker HS; Weiss C; Brannan TS
Res Commun Chem Pathol Pharmacol; 1983 Jun; 40(3):355-66. PubMed ID: 6622814
[TBL] [Abstract][Full Text] [Related]
11. Increased oxidative stress created by adenoviral MnSOD or CuZnSOD plus BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea) inhibits breast cancer cell growth.
Weydert CJ; Zhang Y; Sun W; Waugh TA; Teoh ML; Andringa KK; Aykin-Burns N; Spitz DR; Smith BJ; Oberley LW
Free Radic Biol Med; 2008 Mar; 44(5):856-67. PubMed ID: 18155673
[TBL] [Abstract][Full Text] [Related]
12. [Effect of BCNU on glutathione metabolism in human blood cells].
Benöhr HC; Waller HD
Klin Wochenschr; 1979 Aug; 57(16):845-50. PubMed ID: 502351
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the inhibition of glutathione reductase and the recovery of enzyme activity in exponentially growing murine leukemia (L1210) cells treated with 1,3-bis(2-chloroethyl)-1-nitrosourea.
Cohen MB; Duvel DL
Biochem Pharmacol; 1988 Sep; 37(17):3317-20. PubMed ID: 3401259
[TBL] [Abstract][Full Text] [Related]
14. Differential inhibition of cellular glutathione reductase activity by isocyanates generated from the antitumor prodrugs Cloretazine and BCNU.
Rice KP; Penketh PG; Shyam K; Sartorelli AC
Biochem Pharmacol; 2005 May; 69(10):1463-72. PubMed ID: 15857610
[TBL] [Abstract][Full Text] [Related]
15. Defenses against oxidation in human erythrocytes: role of glutathione reductase in the activation of glucose decarboxylation by hemolytic drugs.
Hohl RJ; Kennedy EJ; Frischer H
J Lab Clin Med; 1991 Apr; 117(4):325-31. PubMed ID: 1901343
[TBL] [Abstract][Full Text] [Related]
16. A role for glutathione and glutathione reductase in control of corneal hydration.
Riley MV
Exp Eye Res; 1984 Dec; 39(6):751-8. PubMed ID: 6519203
[TBL] [Abstract][Full Text] [Related]
17. Enhanced oxygen toxicity following treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea.
Kehrer JP; Paraidathathu T
Fundam Appl Toxicol; 1984 Oct; 4(5):760-7. PubMed ID: 6510607
[TBL] [Abstract][Full Text] [Related]
18. The effect of BCNU (carmustine) on tissue glutathione reductase activity.
Kehrer JP
Toxicol Lett; 1983 Jun; 17(1-2):63-8. PubMed ID: 6623510
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human glutathione reductase by the nitrosourea drugs 1,3-bis(2-chloroethyl)-1-nitrosourea and 1-(2-chloroethyl)-3-(2-hydroxyethyl)-1-nitrosourea. A crystallographic analysis.
Karplus PA; Krauth-Siegel RL; Schirmer RH; Schulz GE
Eur J Biochem; 1988 Jan; 171(1-2):193-8. PubMed ID: 3338461
[TBL] [Abstract][Full Text] [Related]
20. Reduction of glutathione levels in livers of mice treated with N,N'-bis (2-chloroethyl)-N-nitrosourea.
McConnell WR; Kari P; Hill DL
Cancer Chemother Pharmacol; 1979; 2(3):221-3. PubMed ID: 455578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
